IP-led research
Developing research with a focus on differentiated approaches and intellectual property.
Investing in AI-enabled discovery
Arviva Therapeutics brings together AI, biological research and a focus on unmet medical needs. Our strategy is to build long-term value through drug discovery, intellectual property and scientific collaboration.
From research to partnership
Collaborative development
Licensing, joint research and co-development
A focused research portfolio
Neuroscience and metabolic disease
Exploring opportunities that complement our research priorities
Long-term scientific value
Our development approach
We seek partnerships that connect AI-enabled research with pharmaceutical development. Our approach includes intellectual property, co-development and licensing opportunities.
Long-term development
Exploring partnerships and development opportunities that support the long-term progress of our research.
Licensing & collaboration
Working toward licensing and co-development opportunities with pharmaceutical and biotechnology partners.
Partner in AI-enabled discovery
Discuss collaboration